Pentoxifylline Treatment in Acute Pancreatitis (AP)

Summary

The purpose of this study was to determine the effects (good and bad) of giving a drug called pentoxifylline to patients with acute pancreatitis.

Timeline

Start

2015-05

Primary completion

2017-04-30

Completion

2017-10-31

Outcome

Missed primary endpoint

registry analysis (superiority test); Pentoxifylline vs Placebo; p = 0.5796; Kruskal-Wallis NCT02487225 ↗

registry analysis (superiority test); Pentoxifylline vs Placebo; p = 0.1109; Kruskal-Wallis NCT02487225 ↗

registry analysis (superiority test); Pentoxifylline vs Placebo; p = 0.1236; Kruskal-Wallis NCT02487225 ↗

registry analysis (superiority test); Pentoxifylline vs Placebo; p = 0.157; Kruskal-Wallis NCT02487225 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pentoxifylline	Small molecule	400 mg	Oral

Indications